DBV Technologies | DBVT - Market Capitalization

Stock Price
21.94
Daily Change
0.71 3.32%
Monthly
-4.09%
Yearly
435.00%
Q1 Forecast
20.91

DBV Technologies reported $813.6M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amarin USD 341M 4M Sep/2025
BioCryst Pharmaceuticals USD 1.23B 115M Dec/2023
BioMarin Pharmaceutical USD 11.99B 575M Feb/2026
DBV Technologies USD 274M 17M Sep/2025
Esperion Therapeutics USD 340M 235M Dec/2023
Galectin Therapeutics USD 103M 11M Dec/2023
Halozyme Therapeutics USD 10.23B 2.31B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Insmed USD 23.91B 13.21B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Neurocrine Biosciences USD 13.68B 465M Feb/2026
PTC Therapeutics USD 5.36B 744M Feb/2026
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
United Therapeutics USD 18.96B 6B Sep/2025